Biomarkers and prognostic factors for mesothelioma
Authors:
- Harvey I. PassHPHarvey I. Pass
- Harvey I.HIHarvey I.
Open Access
- 1 November 2012
- journal article
- research article
- Vol. 1 (4) , 449-456-456
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Epithelial Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy: Stratification of Survival With CT-Derived Tumor VolumeAmerican Journal of Roentgenology, 2012
- Aquaporin 1 is an independent prognostic factor in pleural malignant mesotheliomaCancer, 2011
- Malignant pleural mesothelioma: The standard of care and challenges for future managementCritical Reviews in Oncology/Hematology, 2011
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic TherapyClinical Cancer Research, 2010
- Survival and Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Study of 314 patients in the West Part of JapanJapanese Journal of Clinical Oncology, 2010
- Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factorsThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Diagnostic and Prognostic Value of Soluble Mesothelin-Related Proteins in Patients with Malignant Pleural Mesothelioma in Comparison with Benign Asbestosis and Lung CancerJournal of Thoracic Oncology, 2008
- Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patientsThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesotheliomaThorax, 2003
- A Proposed New International TNM Staging System for Malignant Pleural MesotheliomaChest, 1995